Whether the dissociation between toxicity and α-synuclein inclusion will be a possible therapy for Parkinson's disease or not?

Mov Disord. 2017 Feb;32(2):210. doi: 10.1002/mds.26912.

Authors

Reyhane Ebrahimi^{1

2}, Soheila Sobhani^{1

3}, Maryam Abbastabar³

Affiliations

¹ Students'Scientific Research Center Tehran University of Medical Sciences Tehran, Iran.
² Clinical Biochemistry Department School of Medicine Faculty of Medicine Tehran University of Medical Sciences Tehran, Iran.
³ Basir Eye Health Research Center Tehran, Iran.

PMID: 28218457
DOI: 10.1002/mds.26912

No abstract available

Publication types

Comment

MeSH terms

Humans
Inclusion Bodies
Parkinson Disease*
alpha-Synuclein*

Substances

alpha-Synuclein